Control of SIV infection and subsequent induction of pandemic H1N1 immunity in rhesus macaques using an Ad5 [E1-, E2b-] vector platform-Reference-Cited by-同舟云学术

Control of SIV infection and subsequent induction of pandemic H1N1 immunity in rhesus macaques using an Ad5 [E1-, E2b-] vector platform

Published:2012-11 Issue:50 Volume:30 Page:7265-7270
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Gabitzsch Elizabeth S.,Balint-Junior Joseph P.,Xu Younong,Balcaitis Stephanie,Sanders-Beer Brigitte,Karl Julie,Weinhold Kent J.,Paessler Slobodan,Jones Frank R.

Funder

NIH-NIAID

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference35 articles.

1. Adenovirus vector-induced immune responses in nonhuman primates: responses to prime boost regimens;Tatsis;J Immunol,2009

2. Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors;McCoy;J Virol,2007

3. Phase I safety and immnogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector;Cantanzaro;J Infect Dis,2006

4. Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults;Priddy;Clin Infect Dis,2008

5. International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations;Barouch;Vaccine,2011

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs;Vaccine;2019-10

2. Construction, expression and antiviral activity analysis of recombinant adenovirus expressing human IFITM3 in vitro;International Journal of Biological Macromolecules;2019-06

3. Vaccines and Immunostimulants;Holland-Frei Cancer Medicine;2017-02-26

4. The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic;Oncotarget;2015-09-07

5. The Ad5 [E1-, E2b-]-based vector: a new and versatile gene delivery platform;Advances in Global Health through Sensing Technologies 2015;2015-05-13